| | | | |
CUSIP NO. 14171W103 | | 13G/A | | Page 8 of 12 Pages |
Item 1(a). | Name of Issuer: |
CareMax, Inc. (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
100 NW 57 Court, Suite 400
Miami, Florida 33126
Item 2(a). | Name of Person Filing: |
This statement (this “Statement”) is filed by the following persons (the “Reporting Persons”):
Athyrium Opportunities III Acquisition LP (“Acquisition”)
Athyrium Opportunities III Acquisition 2 LP (“Acquisition 2” and, together with Acquisition, the “Acquisition Funds”)
Athyrium Opportunities Associates III LP (“Associates III LP”)
Athyrium Opportunities Associates III GP LLC (“Associates III GP”)
Athyrium Funds GP Holdings LLC (“Funds GP Holdings”)
Jeffrey A. Ferrell (“Mr. Ferrell”)
The Reporting Persons’ beneficial ownership of the Issuer’s shares of Common Stock reported herein consist of Class A Common Stock, par value $0.0001 per share, held directly by the Acquisition Funds.
Pursuant to Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the Reporting Persons have entered into an agreement with respect to the joint filing of this Statement, which agreement is set forth on the signature page to this Statement.
Item 2(b). | Address of Principal Business Office or, if none, Residence: |
The principal business office address for each of the Reporting Persons is:
c/o Athyrium Capital Management, LP
505 Fifth Avenue, Floor 18
New York, New York 10017
The Acquisition Funds and Associates III LP are Delaware limited partnerships.
Associates III GP and Funds GP Holdings are Delaware limited liability companies.
Mr. Ferrell is a United States citizen.
Item 2(d). | Title of Class of Securities: |
Class A Common Stock, par value $0.0001 per share, of the Issuer (“Common Stock”)
14171W103